EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chromatin Remodeling in Cancer Stemness, Plasticity, and Therapeutic Resistance: Mechanisms and Targeted Strategies

Shasha Li, Huixia Zhang, Mengyuan Hu, Xiaolei Huo, Wei Xiong, Hao Zhang, Yiqiang Zhang

Cancer Biome and Targeted Therapy · 14.11.2026 · 218-251

DOI: 10.66505/cbtt.v1i4.60 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biome and Targeted Therapy, online erschienen am 14.11.2026. Verfasst von Shasha Li und 6 weiteren Autor:innen. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells (CSCs) comprise phenotypically plastic tumor-cell states associated with tumor propagation, recurrence, and resistance to therapy. Their self-renewal, differentiation potential, and phenotypic plasticity are shaped by genetic, transcriptional, metabolic, and epigenetic mechanisms, including ATP-dependent chromatin remodeling. This article reviews recent research on how chromatin remodeling regulates CSC characteristics. It first summarizes current research on how chromatin remodeling profoundly affects core stemness-related transcriptional networks and key signaling pathways through mechanisms such as changes in chromatin accessibility, nucleosome positioning, and histone variant exchange. Furthermore, this article explores how chromatin remodeling endows CSCs with plasticity, enabling them to adapt to microenvironmental stress and leading to therapy resistance. Finally, it analyzes emerging therapeutic strategies targeting specific chromatin remodeling complexes or factors to investigate CSC-associated vulnerabilities and potential approaches to treatment resistance, aiming to provide new theoretical foundations and potential intervention targets for developing more effective precision cancer therapies. Although these regulatory dependencies identify potential therapeutic vulnerabilities across several tumor types, most evidence remains preclinical, and their therapeutic relevance likely depends on tumor lineage, remodeling-complex composition, genomic context, and the extent to which CSC-selective dependencies can be separated from chromatin-remodeling requirements in normal tissues.

Zitieren

APA

Li, S., Zhang, H., Hu, M., Huo, X., Xiong, W., Zhang, H., & Zhang, Y. (2026). Chromatin Remodeling in Cancer Stemness, Plasticity, and Therapeutic Resistance: Mechanisms and Targeted Strategies. Cancer Biome and Targeted Therapy, 218-251. https://doi.org/10.66505/cbtt.v1i4.60

Vancouver

Li S, Zhang H, Hu M, Huo X, Xiong W, Zhang H, et al. Chromatin Remodeling in Cancer Stemness, Plasticity, and Therapeutic Resistance: Mechanisms and Targeted Strategies. Cancer Biome and Targeted Therapy. 2026:218-251. doi:10.66505/cbtt.v1i4.60

BibTeX
@article{Li2026,
  author = {Li, Shasha and Zhang, Huixia and Hu, Mengyuan and Huo, Xiaolei and Xiong, Wei and Zhang, Hao and Zhang, Yiqiang},
  title = {Chromatin Remodeling in Cancer Stemness, Plasticity, and Therapeutic Resistance: Mechanisms and Targeted Strategies},
  journal = {Cancer Biome and Targeted Therapy},
  year = {2026},
  pages = {218--251},
  doi = {10.66505/cbtt.v1i4.60}
}
Kostenlos starten →